Given that the increase in apoptosis and necrosis in uncontrolled proliferating cells is an important therapeutic goal in cancer, perhaps lncRNA PVT1 inhibition using antisense LNA GapmeRs technology, could have a potential to treat AEL [23]. This evidence concerns the gene PVT1 and acute erythroid leukemia.